http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104083360-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11 |
| filingDate | 2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104083360-B |
| titleOfInvention | A kind of Chinese medicine composition for the preparation of anti-aspergillosis medicine |
| abstract | The present invention relates to a kind of Chinese medicine composition for the preparation of anti-aspergillosis medicine, it comprises the component of following weight parts: cinnamic aldehyde: 40 ~ 80 weight portions, Pogostone: 20 ~ 40 weight portions.Pharmaceutical composition of the present invention can be used for the disease that treatment aspergillin infection causes, and as pulmonary's aspergillin infection, comprises whole body system sexuality dye, comprise the heart, brain, liver, kidney, pancreas etc. caused by aspergillosis septicemia.The present invention has filtered out Pogostone in numerous components of oil of Herba Pogostemonis, its bacteriostatic activity is higher, and has good synergistic function with cinnamic aldehyde, and the two uses after being suitable for compatibility, and increase significantly compared with the bacteriostatic activity after cinnamic aldehyde and oil of Herba Pogostemonis compatibility, and safety is good. |
| priorityDate | 2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.